文献速递其他结缔组织病

系统性硬化症皮肤及成纤维细胞中TGF-β诱导基因HIC-5表达增加:一种新的抗纤维化治疗靶点

Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

本研究探讨HIC-5在系统性硬化症(SSc)组织纤维化中的作用,发现受累SSc皮肤及培养的受累皮肤成纤维细胞中HIC-5和COL1A1表达增加,HIC-5敲低可使SSc成纤维细胞COL1产生减少>50%,提示Hic-5参与SSc皮肤成纤维细胞的促纤维化活化并可能成为抗纤维化治疗新靶点。

要点

  • 受累SSc皮肤中HIC-5与COL1A1转录本及Hic-5、COL1、α-SMA蛋白水平较正常皮肤增加。
  • 受累SSc皮肤成纤维细胞HIC-5与COL1A1表达高于同一患者非受累皮肤成纤维细胞。
  • HIC-5 mRNA敲低使SSc成纤维细胞COL1产生减少>50%。

核心结论

  • HIC-5在受累SSc皮肤及成纤维细胞中表达增加,参与SSc皮肤成纤维细胞的促纤维化活化,可能成为SSc抗纤维化治疗的新分子靶点。

研究设计与样本

  • 研究检测了3例弥漫性SSc患者受累皮肤及取自受累与非受累SSc皮肤的皮肤成纤维细胞中HIC-5与COL1A1基因表达。
  • 采用实时PCR、免疫荧光显微镜、Western blotting及小干扰RNA介导的HIC-5敲低进行实验。

主要发现

  • 与正常皮肤相比,临床受累SSc皮肤中HIC-5和COL1A1转录本及Hic-5、1型胶原(COL1)和α-平滑肌肌动蛋白(α-SMA)蛋白水平增加。
  • 与同一患者非受累皮肤成纤维细胞相比,受累SSc皮肤培养的皮肤成纤维细胞中HIC-5和COL1A1表达增加。
  • HIC-5敲低导致SSc皮肤成纤维细胞中COL1产生显著减少。
  • 培养的SSc皮肤成纤维细胞中Hic-5蛋白显著增加。
  • SSc成纤维细胞中HIC-5 mRNA敲低导致COL1产生减少>50%。

临床怎么用

  • HIC-5表达增加可见于受累SSc皮肤及成纤维细胞,HIC-5敲低可减少COL1产生,提示其作为抗纤维化靶点的潜在价值。

局限性

  • 研究为初步结果,所研究的皮肤样本数量少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: SSc is a systemic fibrotic disease affecting skin, numerous internal organs and the microvasculature. The molecular pathogenesis of SSc tissue fibrosis has not been fully elucidated, although TGF-β1 plays a crucial role. The Hic-5 protein encoded by the TGF-β1-inducible HIC-5 gene participates in numerous TGF-β-mediated pathways, however, the role of Hic-5 in SSc fibrosis has not been investigated. The aim of this study was to examine HIC-5 involvement in SSc tissue fibrosis. METHODS: Affected skin from three patients with diffuse SSc and dermal fibroblasts cultured from affected and non-affected SSc skin were examined for HIC-5 and COL1A1 gene expression. Real-time PCR, IF microscopy, western blotting and small interfering RNA-mediated HIC-5 were performed. RESULTS: HIC-5 and COL1A1 transcripts and Hic-5, type 1 collagen (COL1) and α-smooth muscle actin (α-SMA) protein levels were increased in clinically affected SSc skin compared with normal skin and in cultured dermal fibroblasts from affected SSc skin compared with non-affected skin fibroblasts from the same patients. HIC-5 knockdown caused a marked reduction of COL1 production in SSc dermal fibroblasts. CONCLUSION: HIC-5 expression is increased in affected SSc skin compared with skin from normal individuals. Affected SSc skin fibroblasts display increased HIC-5 and COL1A1 expression compared with non-affected skin fibroblasts from the same patients. Hic-5 protein was significantly increased in cultured SSc dermal fibroblasts. HIC-5 mRNA knockdown in SSc fibroblasts caused >50% reduction of COL1 production. Although these are preliminary results owing to the small number of skin samples studied, they indicate that Hic-5 plays a role in the profibrotic activation of SSc dermal fibroblasts and may represent a novel molecular target for antifibrotic therapy in SSc.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Piera-Velazquez S, Fertala J, Huaman-Vargas G, et al. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target. Rheumatology (Oxford). 2020. PMID: 32442272. doi:10.1093/rheumatology/keaa200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。